Print
Email
Print Edition StoriesThursday, October 22, 2009
Thermo Fisher Q3 revenue falls, net income up on cost cuts
By Julie M. Donnelly
Companies born in the recession
MHT's Julie Donnelly: Life science startups finding investments
MHT's Marc Songini: RI plans launch of cord blood center
Thermo Fisher Scientific Inc., the Waltham-based instrumentation and research products company, is reporting that third-quarter earnings are down 2 percent across both of its core businesses. The analytical technologies segment fell 6 percent, while the laboratory products and services gained 1 percent.
The company did eek out a small Q3 profit gain on cost cutting. Thermo reported net income of $221.2 million on revenues of $2.53 billion in the third quarter of 2009, versus net income of $218.1 million on revenue of $2.59 billion.
The company expects that revenue for the year will be down 4 percent to 5 percent from 2008 levels.
The company narrowed its earnings guidance to $2.95 per share to $3.05 per share, altering its prior view of $2.85 per share to $3.10 per share.
Thermo Fisher announced in September that it had signed a deal to buy in-vitro diagnostics test firm Brahms AG for about $470 million. The German company is to operate as part of the Specialty Diagnostics unit of Thermo Fisher’s Analytical Technologies Segment.
Comments
If you are commenting using a Facebook account, your profile information may be displayed with your comment depending on your privacy settings. By leaving the 'Post to Facebook' box selected, your comment will be published to your Facebook profile in addition to the space below.
RSS Feeds
